Screener
Palvella Therapeutics PVLA Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Palvella Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Palvella Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 8:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-210463
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Prepaid expenses and other current assets | 1,378 | 1,005 |
| Total current assets | 263,231 | 58,987 |
| Operating lease right-of-use assets, net | 528 | 572 |
| Total assets | $263,759 | $59,559 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $5,443 | $4,595 |
| Derivative liabilities – contingent value right liability | — | 2,196 |
Item 1. Financial Statements.
FAQ
- What is Palvella Therapeutics's total assets?
- Palvella Therapeutics (PVLA) reported total assets of $263.76M in Q1 2026.
- How has Palvella Therapeutics's total assets changed year-over-year?
- Palvella Therapeutics's total assets increased by 232.0% year-over-year, from $79.44M to $263.76M.
- What is the long-term trend for Palvella Therapeutics's total assets?
- Over 5 years (2020 to 2025), Palvella Therapeutics's total assets has grown at a -10.7% compound annual growth rate (CAGR), from $105.01M to $59.56M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Palvella Therapeutics's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude